GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 296 filers reported holding GUARDANT HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $234,311 | -25.9% | 6,545 | -51.5% | 0.00% | -40.0% |
| Q1 2023 | $316,393 | -10.8% | 13,498 | +3.5% | 0.01% | -16.7% |
| Q4 2022 | $354,606 | -43.4% | 13,037 | +12.0% | 0.01% | -50.0% |
| Q3 2022 | $627,000 | +36.6% | 11,639 | +2.4% | 0.01% | +33.3% |
| Q2 2022 | $459,000 | -32.9% | 11,370 | +10.2% | 0.01% | -18.2% |
| Q1 2022 | $684,000 | -32.5% | 10,319 | +1.9% | 0.01% | -31.2% |
| Q4 2021 | $1,013,000 | -20.0% | 10,129 | +0.0% | 0.02% | -33.3% |
| Q3 2021 | $1,266,000 | -1.2% | 10,126 | -1.9% | 0.02% | 0.0% |
| Q2 2021 | $1,282,000 | -1.0% | 10,321 | +21.7% | 0.02% | -11.1% |
| Q1 2021 | $1,295,000 | +17.8% | 8,484 | -0.5% | 0.03% | +12.5% |
| Q4 2020 | $1,099,000 | +27.1% | 8,527 | +10.2% | 0.02% | +14.3% |
| Q3 2020 | $865,000 | +37.3% | 7,735 | -0.4% | 0.02% | +31.2% |
| Q2 2020 | $630,000 | – | 7,767 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |